Ozempic Company
- All
- News
- Videos
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
What Is Ozempic 2.0? All You Need To Know About New Needle-Free Weight Loss Drug
The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.
-
Imitation Ozempic Floods Market: Understanding Risks, Costs, and Alternatives
The surge of imitation Ozempic products raises significant health and safety issues for consumers. With brand-name options priced between $800 and $1,000, many are turning to alternatives from compounding pharmacies and unregulated peptide sellers. These alternatives may not be safe or effective, lacking rigorous testing and quality control. As pha...
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
What Is Ozempic 2.0? All You Need To Know About New Needle-Free Weight Loss Drug
The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.
-
Imitation Ozempic Floods Market: Understanding Risks, Costs, and Alternatives
The surge of imitation Ozempic products raises significant health and safety issues for consumers. With brand-name options priced between $800 and $1,000, many are turning to alternatives from compounding pharmacies and unregulated peptide sellers. These alternatives may not be safe or effective, lacking rigorous testing and quality control. As pha...
